Found 6 matching trials
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX PHASE3 The aim of this adaptive Phase 3 trial is to show a statistically significa...
Show More Location
Compassionate Cancer Care Medical Group, Inc
Learn More & Join Trial
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma N/A Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Show More Location
Zhejiang Province Cancer Hospital
Learn More & Join Trial
Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer PHASE2 Based on the safety and benefit of neoadjuvant therapy for patients with pa...
Show More Learn More & Join Trial
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study PHASE1 To investigate the activating effect of local lesion low-dose radiotherapy ...
Show More Location
Zhejiang Provincial People's Hospital
Learn More & Join Trial
AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. PHASE2 The goal of this interventional study is to learn about the clinical effica...
Show More Location
Multiple Locations
Learn More & Join Trial
Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer NA Cancer anorexia-cachexia syndrome is a common and severe complication in pa...
Show More Location
Jinan, Shandong 0531
Learn More & Join Trial